US 11826386
Compositions and methods for treating cancer
granted A61KA61K2039/876A61K2239/31
Quick answer
US patent 11826386 (Compositions and methods for treating cancer) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/876, A61K2239/31, A61K2239/38, A61K2239/57